183 related articles for article (PubMed ID: 9894705)
1. Activated partial thromboplastin time (aPTT) monitoring to achieve therapeutic anticoagulation before and after introducing a nomogram for adjunctive heparin treatment with thrombolytic therapy for acute myocardial infarction.
Chamuleau SA; de Winter RJ
Int J Cardiol; 1998 Dec; 67(3):241-6. PubMed ID: 9894705
[TBL] [Abstract][Full Text] [Related]
2. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
Becker RC; Cannon CP; Tracy RP; Thompson B; Bovill EG; Desvigne-Nickens P; Randall AM; Knatternud G; Braunwald E
Am Heart J; 1996 Mar; 131(3):421-33. PubMed ID: 8604620
[TBL] [Abstract][Full Text] [Related]
3. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.
Granger CB; Hirsch J; Califf RM; Col J; White HD; Betriu A; Woodlief LH; Lee KL; Bovill EG; Simes RJ; Topol EJ
Circulation; 1996 Mar; 93(5):870-8. PubMed ID: 8598077
[TBL] [Abstract][Full Text] [Related]
4. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction.
Flaker GC; Bartolozzi J; Davis V; McCabe C; Cannon CP
Arch Intern Med; 1994 Jul; 154(13):1492-6. PubMed ID: 8018004
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
6. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
[TBL] [Abstract][Full Text] [Related]
7. Variable and circadian response to a fixed high-dose (12 500 IU twice daily) subcutaneous heparin regimen after thrombolytic therapy for acute myocardial infarction.
Violaris AG; Trudgill NJ; Rowlands L; Gunn J; Tsikaderis D; Campbell S
Coron Artery Dis; 1994 Mar; 5(3):257-65. PubMed ID: 8199741
[TBL] [Abstract][Full Text] [Related]
8. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.
Becker RC; Hochman JS; Cannon CP; Spencer FA; Ball SP; Rizzo MJ; Antman EM
J Am Coll Cardiol; 1999 Feb; 33(2):479-87. PubMed ID: 9973029
[TBL] [Abstract][Full Text] [Related]
9. Partial resistance to anticoagulation after streptokinase treatment for acute myocardial infarction.
Zahger D; Maaravi Y; Matzner Y; Gilon D; Gotsman MS; Weiss AT
Am J Cardiol; 1990 Jul; 66(1):28-30. PubMed ID: 2360532
[TBL] [Abstract][Full Text] [Related]
10. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
Antman EM
Circulation; 1996 Sep; 94(5):911-21. PubMed ID: 8790025
[TBL] [Abstract][Full Text] [Related]
11. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
Metz BK; Topol EJ
Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of post-procedural aPTT in patients with ST-elevation myocardial infarction treated with primary PCI.
Kikkert WJ; van Nes SH; Lieve KV; Dangas GD; van Straalen J; Vis M; Baan J; Koch KT; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
Thromb Haemost; 2013 May; 109(5):961-70. PubMed ID: 23446910
[TBL] [Abstract][Full Text] [Related]
13. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
14. Utility of a weight-based heparin nomogram for patients with acute coronary syndromes.
Zimmermann AT; Jeffries WS; McElroy H; Horowitz JD
Intern Med J; 2003; 33(1-2):18-25. PubMed ID: 12534874
[TBL] [Abstract][Full Text] [Related]
15. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Zabel KM; Granger CB; Becker RC; Bovill EG; Hirsh J; Aylward PE; Topol EJ; Califf RM
Am Heart J; 1998 Nov; 136(5):868-76. PubMed ID: 9812083
[TBL] [Abstract][Full Text] [Related]
16. Establishing a new target range for unfractionated heparin for acute coronary syndromes.
Lee MS; Menon V; Schappert J; Wilentz JR; Singh V; Hochman JS
J Thromb Thrombolysis; 2004 Apr; 17(2):121-6. PubMed ID: 15306747
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized comparison of the accuracy of computer-assisted versus GUSTO nomogram--directed heparin therapy.
Mungall DR; Anbe D; Forrester PL; Luoma T; Genovese R; Mahan J; LeBlanc S; Penney JB
Clin Pharmacol Ther; 1994 May; 55(5):591-6. PubMed ID: 8181203
[TBL] [Abstract][Full Text] [Related]
18. Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time.
Bozovich GE; Gurfinkel EP; Antman EM; McCabe CH; Mautner B
Am Heart J; 2000 Oct; 140(4):637-42. PubMed ID: 11011339
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
[TBL] [Abstract][Full Text] [Related]
20. Heparin administration via nomogram versus a standard approach in venous and arterial thromboembolic disease.
Jaff MR; Olin JW; Piedmonte M; Pirzada C; Young JR
Vasc Med; 1996; 1(2):97-101. PubMed ID: 9546934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
